We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Idox Plc | LSE:IDOX | London | Ordinary Share | GB0002998192 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.00 | 1.62% | 62.60 | 61.40 | 62.80 | 62.60 | 62.20 | 62.40 | 2,145,481 | 16:29:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computer Related Svcs, Nec | 73.28M | 5.58M | 0.0122 | 51.31 | 285.78M |
TIDMIDOX
RNS Number : 8401S
IDOX PLC
19 March 2021
This announcement contains inside information
For immediate release
19 March 202 1
Idox plc
Statement regarding Dye & Durham's withdrawal
On 19 February 2021, Idox plc ("Idox" or the "Company") confirmed that it had received a non-binding indicative proposal from Dye & Durham Limited ("Dye & Durham") regarding a possible offer for Idox.
Idox notes the Rule 2.8 announcement now published by Dye & Durham stating that it does not intend to make an offer for Idox.
The Board has engaged constructively with Dye & Durham, maintaining a very clear view of the potential value of the business to its current owners. These discussions have come to an end. Idox remains confident in its future as an independent company and its potential to create further shareholder value.
David Meaden, Chief Executive of Idox, said:
"As announced in our results on 2 February, we look forward to our financial year 2021 with ambition and energy, and executing our strategy of building a business focused on software based activities within the Public Sector and Engineering Information Management markets.
We have now completed the intended reshaping of our Group with the recent disposals of all remaining parts of our Idox Content division, and will look to scale our Group further through carefully selected bolt-on acquisitions. These disposals, together with positive momentum from current trading, have significantly strengthened the group's balance sheet, which in turn offers greater strategic optionality for shareholder value creation."
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain. The person responsible for arranging the release of this announcement on behalf of Idox is Rob Grubb (Chief Financial Officer).
Enquiries:
Idox plc Chris Stone, Non-Executive Chairman David Meaden, Chief Executive Rob Grubb, Chief Financial Officer +44 (0) 870 333 7101 Rothschild & Co (Lead Financial Adviser to Idox) Warner Mandel Anton Black Pietro Franchi +44 (0)20 7280 5000 Peel Hunt (Joint Financial Adviser, NOMAD and broker) Edward Knight Paul Gillam Nick Prowting +44 (0)20 7418 8900 MHP Communications (Financial PR) +44 (0) 203 128 8170 Reg Hoare / James Bavister / Amy idox@mhpc.com O'Sullivan
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
STRSFESMUEFSEID
(END) Dow Jones Newswires
March 19, 2021 03:00 ET (07:00 GMT)
1 Year Idox Chart |
1 Month Idox Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions